SM
Sabby Management Portfolio holdings
AUM
$13M
This Quarter Return
+3.37%
1 Year Return
-26.95%
3 Year Return
-56.43%
5 Year Return
-61.92%
10 Year Return
-71.17%
AUM
$277M
AUM Growth
+$277M
(-4.1%)
Cap. Flow
-$58.1M
Cap. Flow
% of AUM
-20.99%
Top 10 Holdings %
Top 10 Hldgs %
46.92%
Holding
254
New
38
Increased
26
Reduced
76
Closed
42
Top Buys
| 1 |
Bristol-Myers Squibb
BMY
|
$8.46M |
| 2 |
CELG
Celgene Corp
CELG
|
$3.94M |
| 3 |
United Therapeutics
UTHR
|
$3.32M |
| 4 |
TSRO
TESARO, Inc.
TSRO
|
$2.76M |
| 5 |
Tenet Healthcare
THC
|
$2.56M |
Top Sells
| 1 |
Sarepta Therapeutics
SRPT
|
$15.2M |
| 2 |
VXZ
iPath S&P 500 VIX Mid-Term Futures ETN due 1/30/2019
VXZ
|
$6.65M |
| 3 |
Abbott
ABT
|
$6.42M |
| 4 |
GBT
Global Blood Therapeutics, Inc.
GBT
|
$4.21M |
| 5 |
SCON
Superconductor Technologies Inc.
SCON
|
$3.87M |
Sector Composition
| 1 | Healthcare | 87.44% |
| 2 | Consumer Staples | 0.39% |
| 3 | Technology | 0.24% |
| 4 | Industrials | 0.1% |
| 5 | Materials | 0.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Enlivex Therapeutics
ENLV
$25M
| $1.36M | 0.05% |
784,057
-46,196
| -6% | -$79.9K |
|
|
ONSIZ
52
DELISTED
Oncobiologics, Inc. Series B Warrant
ONSIZ
| $1.33M | 0.05% |
926,651
+489,728
| +112% | +$704K |
|
|
SIOX
53
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
| $1.3M | 0.05% |
93,109
-96,891
| -51% | -$1.36M |
|
|
SRRA
54
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
| $1.25M | 0.05% |
687,734
+97,723
| +17% | +$178K |
|
|
ENDP
55
DELISTED
Endo International plc
ENDP
| $1.19M | 0.04% |
59,237
-824
| -1% | -$16.6K |
|
56
Capricor Therapeutics
CAPR
$288M
| $1.18M | 0.04% |
357,436
+175,353
| +96% | +$580K |
|
57
Check-Cap
CHEK
$3.92M
| $1.16M | 0.04% |
+585,569
| New | +$1.16M |
|
|
ONTXW
58
DELISTED
Onconova Therapeutics, Inc. Warrants
ONTXW
| $1.12M | 0.04% |
+725,434
| New | +$1.12M |
|
59
MannKind Corp
MNKD
$1.7B
| $1.11M | 0.04% |
+1,785,368
| New | +$1.11M |
|
60
Imunon
IMNN
$14.4M
| $1.09M | 0.04% |
894,406
-624,959
| -41% | -$762K |
|
|
RIBT
61
DELISTED
RiceBran Technologies
RIBT
| $1.07M | 0.04% |
794,436
+8,960
| +1% | +$12.1K |
|
|
BCLI
62
DELISTED
BRAINSTORM CELL THERAPUTC
BCLI
| $1.06M | 0.04% |
444,500
-32,219
| -7% | -$77K |
|
|
STML
63
DELISTED
Stemline Therapeutics, Inc.
STML
| $1.06M | 0.04% |
+98,050
| New | +$1.06M |
|
|
OCRX
64
DELISTED
Ocera Therapeutics, Inc.
OCRX
| $1.06M | 0.04% |
400,035
-24,000
| -6% | -$63.6K |
|
|
CALA
65
DELISTED
Calithera Biosciences, Inc
CALA
| $1.06M | 0.04% |
+324,500
| New | +$1.06M |
|
66
Traws Pharma
TRAW
$11.1M
| $1.04M | 0.04% |
+392,023
| New | +$1.04M |
|
|
ADYX
67
DELISTED
Adynxx, Inc. Common Stock
ADYX
| $1.03M | 0.04% |
1,321,726
-178,274
| -12% | -$139K |
|
68
CEL-SCI Corp
CVM
$81.1M
| $1.03M | 0.04% |
3,372,642
-4,791,174
| -59% | -$1.46M |
|
|
DRWI
69
DELISTED
DragonWave Inc
DRWI
| $1.02M | 0.04% |
+378,338
| New | +$1.02M |
|
70
vTv Therapeutics
VTVT
$47.5M
| $969K | 0.04% |
134,747
-5,000
| -4% | -$36K |
|
|
IMMU
71
DELISTED
Immunomedics Inc
IMMU
| $966K | 0.04% |
297,310
-127,690
| -30% | -$415K |
|
72
Champions Oncology
CSBR
$96.5M
| $905K | 0.03% |
538,593
-8,135
| -1% | -$13.7K |
|
|
ONSIW
73
DELISTED
Oncobiologics, Inc. Series A Warrant Expiring 2/18/2019
ONSIW
| $905K | 0.03% |
902,050
+475,866
| +112% | +$477K |
|
74
Palisade Bio
PALI
$6.06M
| $892K | 0.03% |
2,787,745
-3,716,055
| -57% | -$1.19M |
|
|
RDHL
75
Redhill Biopharma
RDHL
$2.94M
| $888K | 0.03% |
63,800
-83,700
| -57% | -$1.16M |
|